Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue

Oncology Nursing Forum

Volumn 36, Issue 5, 2009, Pages 519-524

  Wood, Lisa J ^a   Nail, Lillian M ^a   Winters, Kerri A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; EXERCISE; FATIGUE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NEOPLASM; PHYSIOLOGY; SECRETION; SKELETAL MUSCLE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; EXERCISE; FATIGUE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-1BETA; INTERLEUKIN-6; MUSCLE, SKELETAL; NEOPLASMS; PITUITARY-ADRENAL SYSTEM; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949320723     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/09.ONF.519-524     Document Type: Article

References (51)

1. Andersen, K., & Pedersen, B.K. (2008). The role of inflammation in vascular insulin resistance with focus on Il-6. Hormone and Metabolic Research, 40(9), 635-639.
2. Badger, A.M., Bradbeer, J.N., Votta, B., Lee, J.C., Adams, J.L., & Griswold, D.E. (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock, and immune function. Journal of Pharmacology and Experimental Therapeutics, 279(3), 1453-1461. (Pubitemid 27166795)
3. Barber, A.E., Coyle, S.M., Fischer, E., Smith, C., van der Poll, T., Shires, G.T., et al. (1995). Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery, 118(2), 406-410.
4. Bower, J.E., Ganz, P.A., Aziz, N., & Fahey, J.L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604-611. (Pubitemid 34791163)
5. Branger, J., van den Blink, B., Weijer, S., Madwed, J., Bos, C.L., Gupta, A., et al. (2002). Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Journal of Immunology, 168(8), 4070-4077. (Pubitemid 34298414)
6. Brenner, I.K., Natale, V.M., Vasiliou, P., Moldoveanu, A.I., Shek, P.N., & Shephard, R.J. (1999). Impact of three different types of exercise on components of the inflammatory response. European Journal of Applied Physiology and Occupational Physiology, 80(5), 452-460. (Pubitemid 29440509)
7. Bruunsgaard, H., Galbo, H., Halkjaer-Kristensen, J., Johansen, T.L., MacLean, D.A., & Pedersen, B.K. (1997). Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. Journal of Physiology, 499(Pt. 3), 833-841. (Pubitemid 27153602)
8. Clarkson, P.M., Kearns, A.K., Rouzier, P., Rubin, R., & Thompson, P.D. (2006). Serum creatine kinase levels and renal function measures in exertional muscle damage. Medicine and Science in Sports and Exercise, 38(4), 623-627.
9. Cramp, F., & Daniel, J. (2008). Exercise for the management of cancerrelated fatigue in adults. Cochrane Database of Systematic Reviews, 2, CD006145.
10. Dandona, P., Aljada, A., Garg, R., & Mohanty, P. (1999). Increase in plasma interleukin-10 following hydrocortisone injection. Journal of Clinical Endocrinology and Metabolism, 84(3), 1141-1144. (Pubitemid 29138256)
11. Dantzer, R., & Kelley, K.W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 21(2), 153-160. (Pubitemid 46038917)
12. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G., & de Vries, J.E. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine, 174(5), 1209-1220.
13. Ding, A.H., Porteu, F., Sanchez, E., & Nathan, C.F. (1990). Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science, 248(4953), 370-372.
14. Elsea, C.R., Roberts, D.A., Druker, B.J., & Wood, L.J. (2008). Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS ONE, 3(6), e2355.
15. Febbraio, M.A., Steensberg, A., Keller, C., Starkie, R.L., Nielsen, H.B., Krustrup, P., et al. (2003). Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. Journal of Physiology, 549(Pt. 2), 607-612. (Pubitemid 36701770)
16. Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., et al. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. Journal of Experimental Medicine, 177(2), 547-550. (Pubitemid 23117107)
17. Goldblatt, F., & Isenberg, D.A. (2005). New therapies for rheumatoid arthritis. Clinical and Experimental Immunology, 140(2), 195-204. (Pubitemid 40559145)
18. Holscher, C., Mohrs, M., Dai, W.J., Kohler, G., Ryffel, B., Schaub, G.A., et al. (2000). Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infection and Immunity, 68(7), 4075-4083. (Pubitemid 30434562)
19. Irvine, D., Vincent, L., Graydon, J.E., Bubela, N., & Thompson, L. (1994). The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nursing, 17(5), 367-378. (Pubitemid 24300143)
20. Keller, C., Keller, P., Giralt, M., Hidalgo, J., & Pedersen, B.K. (2004). Exercise normalizes overexpression of TNF-alpha in knockout mice. Biochemical and Biophysical Research Communications, 321(1), 179-182. (Pubitemid 39055621)
21. Keller, C., Steensberg, A., Pilegaard, H., Osada, T., Saltin, B., Pedersen, B.K., et al. (2001). Transcriptional activation of the Il-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content. Faseb Journal, 15(14), 2748-2750.
22. Lang, C.H., Silvis, C., Deshpande, N., Nystrom, G., & Frost, R.A. (2003). Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock, 19(6), 538-546.
23. Lundberg, I.E., & Nader, G.A. (2008). Molecular effects of exercise in patients with inflammatory rheumatic disease. Nature Clinical Practice. Rheumatology, 4(11), 597-604.
24. Mant, T.G., Borozdenkova, S., Bradford, D.B., Allen, E., Amin, D.M., Toothaker, R.D., et al. (2008). Changes in HLA-DR expression, cytokine production, and coagulation following endotoxin infusion in healthy human volunteers. International Immunopharmacology, 8(5), 701-707.
25. Michael, Y.L., Kawachi, I., Berkman, L.F., Holmes, M.D., & Colditz, G.A. (2000). The persistent impact of breast carcinoma on functional health status: Prospective evidence from the Nurses' Health Study. Cancer, 89(11), 2176-2186.
26. Mock, V., Dow, K.H., Meares, C.J., Grimm, P.M., Dienemann, J.A., Haisfield- Wolfe, M.E., et al. (1997). Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncology Nursing Forum, 24(6), 991-1000.
27. Muhl, H., Nold, M., Chang, J.H., Frank, S., Eberhardt, W., & Pfeilschifter, J. (1999). Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. European Journal of Immunology, 29(10), 3225-3235. (Pubitemid 29484213)
28. National Comprehensive Cancer Network. (2009). Clinical Practice Guidelines in OncologyTM: Cancer-related fatigue [v.1.2009]. Jenkintown, PA: Author.
29. Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., et al. (2005). Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood, 106(8), 2627-2632. (Pubitemid 41510733)
30. Omdal, R., & Gunnarsson, R. (2004). The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis-A pilot study. Rheumatology International, 25(6), 481-484. (Pubitemid 41186922)
31. Ostrowski, K., Hermann, C., Bangash, A., Schjerling, P., Nielsen, J.N., & Pedersen, B.K. (1998). A trauma-like elevation of plasma cytokines in humans in response to treadmill running. Journal of Physiology, 513(Pt. 3), 889-894. (Pubitemid 29008116)
32. Ostrowski, K., Rohde, T., Asp, S., Schjerling, P., & Pedersen, B.K. (1999). Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. Journal of Physiology, 515(Pt. 1), 287-291. (Pubitemid 29092641)
33. Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B.K. (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. Journal of Physiology, 508(Pt. 3), 949-953. (Pubitemid 28220743)
34. Ostrowski, K., Schjerling, P., & Pedersen, B.K. (2000). Physical activity and plasma interleukin-6 in humans-Effect of intensity of exercise. European Journal of Applied Physiology, 83(6), 512-515. (Pubitemid 32014240)
35. Paiva, E.S., Deodhar, A., Jones, K.D., & Bennett, R. (2002). Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin tone. Arthritis and Rheumatism, 46(5), 1344-1350. (Pubitemid 34525844)
36. Pedersen, B.K. (2006). The anti-inflammatory effect of exercise: Its role in diabetes and cardiovascular disease control. Essays in Biochemistry, 42, 105-117.
37. Pedersen, B.K., & Fischer, C.P. (2007). Physiological roles of musclederived interleukin-6 in response to exercise. Current Opinion in Clinical Nutrition and Metabolic Care, 10(3), 265-271. (Pubitemid 46596700)
38. Schubert, C., Hong, S., Natarajan, L., Mills, P.J., & Dimsdale, J.E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21(4), 413-427. (Pubitemid 46528677)
39. Schwartz, A.L. (1998). Patterns of exercise and fatigue in physically active cancer survivors. Oncology Nursing Forum, 25(3), 485-491.
40. Segar, M.L., Katch, V.L., Roth, R.S., Garcia, A.W., Portner, T.I., Glickman, S.G., et al. (1998). The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncology Nursing Forum, 25(1), 107-113.
41. Steensberg, A., Fischer, C.P., Keller, C., Moller, K., & Pedersen, B.K. (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology Endocrinology and Metabolism, 285(2), E433-E437. (Pubitemid 36899719)
42. Steensberg, A., Keller, C., Starkie, R.L., Osada, T., Febbraio, M.A., & Pedersen, B.K. (2002). IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. American Journal of Physiology Endocrinology and Metabolism, 283(6), E1272-E1278. (Pubitemid 35340635)
43. Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Klarlund Pedersen, B. (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. Journal of Physiology, 529(Pt. 1), 237-242.
44. Thomassen, M.J., Divis, L.T., & Fisher, C.J. (1996). Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clinical Immunology and Immunopathology, 80(3, Pt. 1), 321-324.
45. Tidball, J.G. (2005). Inflammatory processes in muscle injury and repair. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 288(2), R345-R353. (Pubitemid 40129595)
46. Tilg, H., & Moschen, A.R. (2006). Adipocytokines: Mediators linking adipose tissue, inflammation, and immunity. Nature Reviews. Immunology, 6(10), 772-783. (Pubitemid 44453463)
47. Toft, A.D., Jensen, L.B., Bruunsgaard, H., Ibfelt, T., Halkjaer-Kristensen, J., Febbraio, M., et al. (2002). Cytokine response to eccentric exercise in young and elderly humans. American Journal of Physiology Cell Physiology, 283(1), C289-C295. (Pubitemid 34670573)
48. Weinblatt, M.E., Keystone, E.C., Furst, D.E., Moreland, L.W., Weisman, M.H., Birbara, C.A., et al. (2003). Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis and Rheumatism, 48(1), 35-45. (Pubitemid 36091645)
49. White, C.M., Martin, B.K., Lee, L.F., Haskill, J.S., & Ting, J.P. (1998). Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunology and Immunotherapy, 46(2), 104-112. (Pubitemid 28177485)
50. Wood, L.J., Nail, L.M., Gilster, A., Winters, K.A., & Elsea, C.R. (2006). Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncology Nursing Forum, 33(3), 535-542. (Pubitemid 44870222)
51. Wood, L.J., Nail, L.M., Perrin, N.A., Elsea, C.R., Fischer, A., & Druker, B.J. (2006). The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behaviorlike symptoms in a mouse model of cancer chemotherapy-related symptoms. Biological Research for Nursing, 8(2), 157-169. (Pubitemid 44410365)